LPL Financial’s PDS Biotechnology PDSB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-10,412
Closed -$39.8K 5405
2024
Q3
$39.8K Hold
10,412
﹤0.01% 5022
2024
Q2
$30.5K Sell
10,412
-118,053
-92% -$378K ﹤0.01% 4899
2024
Q1
$509K Sell
128,465
-3,062
-2% -$15.8K ﹤0.01% 3762
2023
Q4
$654K Sell
131,527
-103,250
-44% -$513K ﹤0.01% 3432
2023
Q3
$1.19M Sell
234,777
-70,685
-23% -$387K ﹤0.01% 2753
2023
Q2
$1.54M Sell
305,462
-22,785
-7% -$149K ﹤0.01% 2484
2023
Q1
$2.02M Sell
328,247
-50,213
-13% -$411K ﹤0.01% 2131
2022
Q4
$5M Sell
378,460
-114,771
-23% -$810K ﹤0.01% 1453
2022
Q3
$1.47M Buy
493,231
+298,731
+154% +$1.27M ﹤0.01% 2223
2022
Q2
$710K Buy
+194,500
New +$925K ﹤0.01% 2878
2021
Q4
Sell
-45,436
Closed -$677K 4432
2021
Q3
$677K Sell
45,436
-5,614
-11% -$70K ﹤0.01% 2941
2021
Q2
$641K Buy
+51,050
New +$399K ﹤0.01% 2942
2017
Q1
Sell
-634
Closed -$162K 2773
2016
Q4
$162K Buy
+634
New +$144K ﹤0.01% 2526

Other funds holding PDSB

LPL Financial's PDSB Position: Q4 2024 in Review

LPL Financial sold out of PDS Biotechnology (PDSB) in Q4 2024, closing a stake of 10,412 shares — an estimated $39.8K sold.

LPL Financial first reported a position in PDSB in Q4 2016 and held it in 13 quarters. The position peaked at $5M in Q4 2022. 52 funds tracked by Wall St. Rank hold PDSB as of Q4 2024.

  • LPL Financial reported no remaining PDS Biotechnology position as of Q4 2024 after selling out during the quarter.
  • LPL Financial sold 10,412 PDS Biotechnology shares in Q4 2024, an estimated $39.8K.
  • LPL Financial first reported a position in PDS Biotechnology in Q4 2016 and held it in 13 quarters.
  • LPL Financial's PDS Biotechnology position peaked at $5M in Q4 2022.
  • 52 funds tracked by Wall St. Rank held PDS Biotechnology as of Q4 2024.

Based on LPL Financial's 13F filing for Q4 2024, filed 11 Feb 2025.